Hemetron AG is transforming chronic disease management with its remote blood testing platform. Our hand-held device enables patients with inflammatory rheumatic diseases and other chronic conditions to perform laboratory-grade blood tests at home, with results sent digitally to their physicians for timely treatment adjustments.
By closing the gap between infrequent clinical visits and real-time disease monitoring, we help improve outcomes and reduce healthcare costs. Our initial focus is on rheumatology, and we plan to expand to additional biomarkers and disease areas.
We are shaping a future where everyone, from physicians to patients to health enthusiasts, can act on real-time health insights to effectively combat and prevent chronic diseases.
Eight startups join MedTech Booster Program in 2026 (startupticker.ch)
Venture Leaders Medtech Roadshow 2025: Swiss Medtech startups shine in Boston (venturelab.swiss)
New Startup Innovation Projects set to advance their technologies (startupticker.ch)
Hemetron: The Venture Leader Medtech enabling better treatments through accurate mobile health tests (venturelab.swiss)
Venture Leaders Medtech 2025 kick-off their Boston roadshow (venturelab.swiss)
Seven startups selected for the Swiss-Israel Lean Launchpad (startupticker.ch)
Ten Medtech startups to explore US expansion opportunities (startupticker.ch)
Venture Leaders Medtech 2025: Ten Swiss startups selected for US expansion (venturelab.swiss)
Strong Swiss delegation at Medica (startupticker.ch)
InnoBooster projects have high ambitions (startupticker.ch)